• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


The Cultivated B Plans Burlington, Ontario, Bioengineering Facility-Innovation Hub

The Cultivated B, the bioengineering company that provides access to plant-based and cell-based alternative protein sources, will establish its Canadian manufacturing operations and innovation hub in Burlington, Ontario. The C$50 million project is expected to create over 200 jobs within the next year.

The new 130,000-square-foot facility, located at 649 North Service Road, will develop and produce bioreactors from 500 ml ranging up to 25,000 liters, as well as photobioreactors and high-precision devices for cellular agriculture and precision fermentation. This will enable other businesses to produce alternative proteins at an industrial scale, whether that is in the cultivated meat, pharmaceutical, or cosmetic industries.

“This facility in Canada is more than just a production site. Alongside the development and production of pioneering technology and bioreactors, we want to help other enterprises in the cellular agriculture and pharmaceutical industry flourish,” says Hamid R. Noori, Co-Founder and Co-CEO of The Cultivated B. “Our innovation hub, in particular, will help shape the landscape for cellular agriculture in the country and fill a major gap that we saw. We have aligned our goals with the government and Ontario Genomics, and I look forward to seeing how we will drive forward innovation and economic development together.”

In collaboration with Ontario Genomics, approximately 20,000-square-feet of the building will be dedicated to growing an innovation hub, providing smaller and mid-size cellular agriculture and other biotech companies with access to laboratory space, bioreactors and, if needed, mentorship, to test and scale up their products.

“Canada, and specifically Ontario, has an opportunity to be at the forefront of a transformative industry. Our partnership with TCB will support biotechnology startups as they scale up their capacity to produce much needed foods and ingredients,” noted Bettina Hamelin, President and CEO at Ontario Genomics. “There is undeniable growing consumer demand and huge industry momentum for these new and innovative products. This partnership is a critical next step for Canada to act on a window of opportunity to enhance resiliency in food supply chains while meeting common food security and sustainability goals.”

The facility will also house PreFer Industries, a subsidiary of The Cultivated B., focusing on the development of alternative, particularly plant-based protein sources through precision fermentation. PreFer Industries will keep the production of key plant-based resources within Canada and produce them with the desired proteins to optimize their use. This technology will transform a low-value resource, like grains, into something of high value.

“It’s going to create 200 really well-paying jobs. It is going to boost the local economy. But more than that, it's going to pave the way for future innovation in the food and pharmaceutical industries. And, it's also going to help secure Ontario's position as a leader in biotechnology,” added Vic Fedeli, minister of economic development, job creation and trade of Ontario.

The Cultivated B uses cellular agriculture, precision fermentation, and new approaches in bioreactor technology to drive forward the cultivated meat, food production, and personal care industries. By providing pioneering technology, The company enriches the alternative protein and agritech industries and enables other organizations to produce alternative proteins at an industrial scale.

Exclusive Research